Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

MK-677 vs HGH: Secretagogue vs Growth Hormone

MK-677 vs HGH compared: oral secretagogue vs injectable growth hormone, mechanisms, IGF-1 elevation, cost, side effects, evidence grades, and research applications.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

MK-677 vs HGH: Secretagogue vs Exogenous Growth Hormone

MK-677 (ibutamoren) is an oral ghrelin receptor agonist that stimulates endogenous growth hormone release, increasing IGF-1 levels by 40-90% with a convenient once-daily oral dose. HGH (somatropin) is recombinant human growth hormone administered via subcutaneous injection, providing direct supraphysiological GH elevation. This comparison examines the fundamental trade-off between oral convenience and lower cost (MK-677) versus precise dosing and maximal GH elevation (HGH).

Side-by-Side Comparison

Mechanism

Ghrelin receptor (GHSR) agonist; stimulates endogenous GH

Exogenous recombinant human growth hormone

Evidence Grade

B+

A+

Route

Oral (capsule or liquid)

Subcutaneous injection

Typical Dose

10 - 25 mg/day oral

1 - 4 IU/day SC injection

Half-Life

~24 hours

~3-4 hours (GH clearance)

IGF-1 Increase

40 - 90% above baseline

100 - 300%+ (dose-dependent)

GH Release Pattern

Amplified pulsatile (endogenous)

Direct exogenous bolus

Best For

Budget GH optimization, sleep, appetite

Maximum GH elevation, precise dosing, anti-aging

FDA Status

Not FDA-approved; investigational

FDA-approved (GH deficiency)

Cost (monthly)

$30 - $60

$300 - $1,000+

MK-677: Pros & Cons

Advantages

Oral administration (no injections)

Dramatically lower cost (10-20x cheaper)

24-hour half-life allows once-daily dosing

Preserves natural pulsatile GH secretion

Improves sleep quality (deep sleep enhancement)

Significant IGF-1 elevation (40-90%)

Considerations

Significant appetite increase (ghrelin pathway)

May increase cortisol and prolactin

Water retention and bloating common

Cannot achieve supraphysiological GH levels

May worsen insulin sensitivity with long-term use

Not FDA-approved

HGH: Pros & Cons

FDA-approved with extensive safety data

Precise, dose-dependent GH elevation

Strongest evidence for body composition changes

No appetite stimulation via ghrelin

No cortisol or prolactin elevation

Can achieve supraphysiological levels when desired

Requires daily subcutaneous injection

Significantly higher cost ($300-1,000+/month)

Suppresses natural GH production during use

Potential for joint pain, carpal tunnel at high doses

Risk of counterfeit products in research market

Short half-life requires consistent timing

Which Is Right for Your Research?

Decision Guide

Choose MK-677 if: Your research goals include moderate GH/IGF-1 optimization within physiological ranges, improved sleep quality, or long-term GH support at an accessible cost. MK-677 is ideal for protocols where injectable administration is impractical and budget is a primary constraint. Its oral convenience and 24-hour half-life make it the simplest GH-enhancing compound available.

Choose HGH if: Your research requires precise GH dosing, supraphysiological GH levels, the strongest evidence base, or FDA-approved status. HGH is the gold standard for growth hormone research with decades of clinical data. It is essential for protocols studying body composition, anti-aging, or GH deficiency where maximum and controllable GH elevation is needed.

Note: MK-677 is not a replacement for HGH in clinical GH deficiency. Its appetite-stimulating effects and insulin sensitivity concerns should be weighed against its cost and convenience advantages.

Frequently Asked Questions

MK-677 increases IGF-1 by 40-90% but cannot match HGH's supraphysiological peaks. For moderate GH optimization within upper-normal ranges, MK-677 may suffice. For maximum GH elevation and precise dosing, HGH is required. They operate through fundamentally different mechanisms.

Yes, MK-677 costs approximately $30-60/month vs $300-1,000+ for pharmaceutical HGH. This 10-20x cost difference is one of MK-677's primary advantages, making GH optimization accessible for extended research protocols.

Yes, MK-677 significantly increases appetite through ghrelin receptor activation. HGH does not stimulate appetite through the ghrelin pathway. MK-677's hunger effect typically diminishes after 2-4 weeks but can be counterproductive for fat loss protocols.

Related Protocol Guides

Compare More

Verified Research Suppliers

★ LiveWell Peptides — Preferred Vendor • cGMP Certified Preferred vendor

Core Peptides — Third-party tested

— Broad catalog

Biotech Peptides — USA-based

Related Resources

Connected topics

Follow this recovery question